AI assistant
Sending…
CONMED Corp — Director's Dealing 2012
May 18, 2012
31971_dirs_2012-05-18_a66d151c-ca04-42e4-9eab-be6a7a029af9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-05-17
Reporting Person: CORASANTI EUGENE R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-17 | Common Stock | M | 200 | — | Acquired | 68003 | Direct |
| 2012-05-17 | Common Stock | F | 53 | $27.24 | Disposed | 67950 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-17 | Rsus (restricted Stock Units) | $0 | M | 200 | Disposed | 2017-05-17 | Common Stock (200) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7